Neuroscience Expo: Navigating the Increasingly Complex World of Disease-modifying Therapies

Geeta A. Ganesh, M.D., MPH, neurologist, Norton Neuroscience Institute Hussung Family Multiple Sclerosis Center, discusses ways to navigate the complex world of disease-modifying therapies (DMTs). Topics include:
- The timeline for disease-modifying therapies in the U.S.
- The factors used to select a disease-modifying therapy
- How disease-modifying therapies are grouped in terms of efficacy
- How a neurologist decides when it is time to change medications
- Define the term “shared decision-making”